Alzchem Group invests EUR 120M in creatine production facility in Trostberg

Alzchem Group AG adopted a comprehensive investment program of around EUR 120 million for further capacity expansion in creatine products. The investment will go into a new, increasingly automated production facility for creatine and its precursors, as well as upstream infrastructure, with commissioning planned in stages starting in the second half of 2027.

“A total of around EUR 120 million is to be invested in the construction of a new, increasingly automated production facility for creatine and its precursors, as well as in the upstream infrastructure.”alzchem.com

• 1 source
• alzchem.comInvestment program worth around EUR 120 million | Alzchem GroupDec 4, 2025

Summarized from public sources; check the original articles before acting on it.